4//SEC Filing
Homans Elizabeth 4
Accession 0001209191-21-055899
CIK 0001806952other
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 4:17 PM ET
Size
5.3 KB
Accession
0001209191-21-055899
Insider Transaction Report
Form 4
Homans Elizabeth
DirectorChief Executive Officer
Transactions
- Award
Option (right to buy)
2021-09-13+1,370,469→ 1,370,469 totalExercise: $16.05Exp: 2031-09-12→ Common Stock (1,370,469 underlying)
Footnotes (1)
- [F1]The shares vest in equal monthly installments over the forty-eight months following September 13, 2021.
Documents
Issuer
Lyell Immunopharma, Inc.
CIK 0001806952
Entity typeother
Related Parties
1- filerCIK 0001866220
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 4:17 PM ET
- Size
- 5.3 KB